CAS: 1365267-27-1 - X-396
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | X-376 REF: AN-AG009ID7CAS: 1365267-27-1 | 99% | 53.00 €~165.00 € | Wed 08 May 24 |
 | X-376 REF: TM-T3550CAS: 1365267-27-1 | 98.72% | 35.00 €~568.00 € | Wed 15 May 24 |
 | X 396 REF: 3D-FX103675CAS: 1365267-27-1 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG009ID7
| 2mg | 53.00 € | |
| 5mg | 68.00 € | |
| 10mg | 88.00 € | |
| 25mg | 115.00 € | |
| 50mg | 128.00 € | |
| 100mg | 137.00 € | |
| 250mg | 165.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
X-376
CAS:1365267-27-1
X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic …
Formula:
C25H25Cl2FN6O3
Purity:
98.72%
Color and Shape:
Solid
Molecular weight:
547.41
Ref: TM-T3550
| 1mg | 35.00 € | |
| 2mg | 51.00 € | |
| 5mg | 96.00 € | |
| 10mg | 118.00 € | |
| 25mg | 254.00 € | |
| 50mg | 418.00 € | |
| 100mg | 568.00 € | |
| 1ml*10 (DMSO) | 103.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
X 396
CAS:1365267-27-1
X 396 is a tyrosine kinase inhibitor that is being investigated in a multicenter phase …
Formula:
C25H25Cl2FN6O3
Purity:
Min. 95%
Molecular weight:
547.41 g/mol
Ref: 3D-FX103675
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
